These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1688986)

  • 1. The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.
    Oti-Amoako K; Vozeh S; Ha HR; Follath F
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):75-81. PubMed ID: 1688986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.
    Thompson KA; Iansmith DH; Siddoway LA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1988 Mar; 244(3):950-5. PubMed ID: 3252042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG; Kirsten EB; Brewington J
    Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K; Lindner W; Schnedl H; Kukovetz WR
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propafenone and its metabolites preferentially inhibit IKr in rabbit ventricular myocytes.
    Cahill SA; Gross GJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):59-65. PubMed ID: 14569067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
    Funck-Brentano C; Kroemer HK; Pavlou H; Woosley RL; Roden DM
    Br J Clin Pharmacol; 1989 Apr; 27(4):435-44. PubMed ID: 2719900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE; Yee YG; Winkle RA
    Clin Pharmacol Ther; 1985 Jun; 37(6):610-4. PubMed ID: 4006362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers.
    Woodland C; Verjee Z; Giesbrecht E; Koren G; Ito S
    J Pharmacol Exp Ther; 1997 Oct; 283(1):39-45. PubMed ID: 9336306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of R- and S-propafenone and of the main metabolite in plasma.
    Böhm R; Ellrich R; Koytchev R
    Pharmazie; 1995 Aug; 50(8):542-5. PubMed ID: 7568317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography.
    Shirayama Y; Doki K; Sekiguchi Y; Aonuma K; Kohda Y; Homma M
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28929504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective disposition and pharmacologic activity of propafenone enantiomers.
    Kroemer HK; Funck-Brentano C; Silberstein DJ; Wood AJ; Eichelbaum M; Woosley RL; Roden DM
    Circulation; 1989 May; 79(5):1068-76. PubMed ID: 2713973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
    Kern R
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):203-10. PubMed ID: 7913980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
    Fonck K; Haenebalcke C; Hemeryck A; Belpaire F; Jordaens L; Calle P; Buylaert W
    J Toxicol Clin Toxicol; 1998; 36(3):247-51. PubMed ID: 9656983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.
    Wascher TC; Dittrich P; Kukovetz WR
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):473-7. PubMed ID: 1620247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration dependent stereoselectivity of propafenone N-depropylation metabolism with human hepatic recombinant CYP1A2.
    Zhou Q; Yao TW; Yu YN; Zeng S
    Pharmazie; 2003 Sep; 58(9):651-3. PubMed ID: 14531463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient outward current inhibition by propafenone and 5-hydroxypropafenone in cultured neonatal rat ventricular myocytes.
    Cahill SA; Kirshenbaum LA; Gross GJ
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):460-7. PubMed ID: 11486250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.